Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ioannis G Habeos"'
Autor:
Panos Ziros, Zoi Zagoriti, George Lagoumintzis, Venetsana Kyriazopoulou, Ralitsa P Iskrenova, Evagelia I Habeos, Gerasimos P Sykiotis, Dionysios V Chartoumpekis, Ioannis G Habeos
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0162024 (2016)
Fibroblast growth factor 21 (Fgf21) is a hormone with emerging beneficial roles in glucose and lipid homeostasis. The interest in Fgf21 as a potential antidiabetic drug and the factors that regulate its production and secretion is growing. Statins ar
Externí odkaz:
https://doaj.org/article/0002538f54ee4b8aa8030916319718a9
Autor:
Dionysios V Chartoumpekis, Apostolos Zaravinos, Panos G Ziros, Ralitsa P Iskrenova, Agathoklis I Psyrogiannis, Venetsana E Kyriazopoulou, Ioannis G Habeos
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e34872 (2012)
Obesity is a major health concern worldwide which is associated with increased risk of chronic diseases such as metabolic syndrome, cardiovascular disease and cancer. The elucidation of the molecular mechanisms involved in adipogenesis and obesogenes
Externí odkaz:
https://doaj.org/article/570c2d09f4ba4b4e994bc22bc6e327cd
Publikováno v:
Free radical biologymedicine. 190
The signaling pathway centered on the transcription factor nuclear erythroid factor 2-like 2 (Nrf2) has emerged during the last 15 years as a target for the prevention and treatment of diseases broadly related with oxidative stress such as cancer, ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::672853922f05df4f1389603184879832
https://pubmed.ncbi.nlm.nih.gov/35988853
https://pubmed.ncbi.nlm.nih.gov/35988853
Autor:
Panos G, Ziros, Cédric O, Renaud, Dionysios V, Chartoumpekis, Massimo, Bongiovanni, Ioannis G, Habeos, Xiao-Hui, Liao, Samuel, Refetoff, Peter A, Kopp, Klaudia, Brix, Gerasimos P, Sykiotis
Publikováno v:
Thyroid
Background: Familial nontoxic multinodular goiter (MNG) is a rare disease. One of the associated genes is Kelch-like ECH-associated protein 1 (KEAP1), which encodes the main inhibitor of nuclear factor erythroid 2-related transcription factor 2 (Nrf2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e961c8bf64875984cfc5d413255ae20e
https://pubmed.ncbi.nlm.nih.gov/32689903
https://pubmed.ncbi.nlm.nih.gov/32689903
Publikováno v:
Anticancer research. 26(3B)
Capecitabine is a tumor-activated oral fluoropyrimidine with established antitumor activity in breast and colorectal cancer. Hypertriglyceridemia associated with this drug has rarely been reported in the literature.This is a report of two patients wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::deeadd57fc66f393a48853594816472d
https://pubmed.ncbi.nlm.nih.gov/16821596
https://pubmed.ncbi.nlm.nih.gov/16821596
Autor:
Marina A. Michalaki, Apostolos G. Vagenakis, Aggeliki S. Leonardou, Marianna N. Argentou, Ioannis G. Habeos, Maria G. Makri, Agathoklis I. Psyrogiannis, Fotis E. Kalfarentzos, Venetsana E. Kyriazopoulou
Publikováno v:
Thyroid; Jan2006, Vol. 16 Issue 1, p73-78, 6p